go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

GlaxoSmithKline Consumer Healthcare (Ireland) Ltd

GlaxoSmithKline Consumer Healthcare (Ireland) Ltd
Stonemason's Way, Rathfarnham, Dublin 16,
Telephone: +353 1 495 5000
Fax: +353 1 495 5105
Medical Information Direct Line: +353 1 800 244 255
Medical Information Facsimile: +353 1 495 5242


Summary of Product Characteristics last updated on medicines.ie: 22/10/2010
SPC Corsodyl 0.2% w/v Mint Mouthwash

Table of Contents

  • 1. NAME OF THE MEDICINAL PRODUCT
  • 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
  • 3. PHARMACEUTICAL FORM
  • 4. CLINICAL PARTICULARS
  • 4.1 Therapeutic indications
  • 4.2 Posology and method of administration
  • 4.3 Contraindications
  • 4.4 Special warnings and precautions for use
  • 4.5 Interaction with other medicinal products and other forms of interaction
  • 4.6 Pregnancy and lactation
  • 4.7 Effects on ability to drive and use machines
  • 4.8 Undesirable effects
  • 4.9 Overdose
  • 5. PHARMACOLOGICAL PROPERTIES
  • 5.1 Pharmacodynamic properties
  • 5.2 Pharmacokinetic properties
  • 5.3 Preclinical safety data
  • 6. PHARMACEUTICAL PARTICULARS
  • 6.1 List of excipient(s)
  • 6.2 Incompatibilities
  • 6.3 Shelf life
  • 6.4 Special precautions for storage
  • 6.5 Nature and contents of container
  • 6.6 Special precautions for disposal and other handling
  • 7. MARKETING AUTHORISATION HOLDER
  • 8. MARKETING AUTHORISATION NUMBER(S)
  • 9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
  • 10. DATE OF REVISION OF THE TEXT


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Corsodyl 0.2% w/v Mint Mouthwash


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Chlorhexidine Digluconate 0.2% w/v

(as Chlorhexidine Digluconate Solution)

Excipients: Contains Macrogolglycerol Hydroxystearate 0.8% w/v

For a full list of excipients, see section 6.1.


Go to top of the page
3. PHARMACEUTICAL FORM

Mouthwash

A clear or slightly opalescent, colourless solution with an odour of peppermint.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the inhibition of the formation of dental plaque.

As an aid in the treatment and prevention of gingivitis, and in the maintenance of oral hygiene, particularly in situations where toothbrushing cannot be adequately employed (e.g. following oral surgery or in physically or mentally handicapped patients).

Also for use in a post-periodontal surgery or treatment regimen to promote gingival healing.

It is useful in the management of aphthous ulceration and oral candidal infections (e.g. denture stomatitis and thrush).


Go to top of the page
4.2 Posology and method of administration

Adults:

Thoroughly rinse the mouth for about one minute with 10 ml twice daily. In the dental surgery the patient should be instructed to rinse the mouth with 10 ml for one minute prior to treatment.

Corsodyl Mouthwash is incompatible with anionic agents which are usually present in conventional dentifrices. These should therefore be used before Corsodyl Mouthwash (rinsing the mouth between applications) or at a different time of day.

For the treatment of gingivitis, a course of about one month is advisable although some variation in response is to be expected. In the case of aphthous ulceration and oral candidal infections, treatment should be continued for 48 hours after clinical resolution. For the treatment of denture stomatitis the dentures should be cleansed and soaked in Corsodyl Mouthwash for fifteen minutes twice daily.

Children and the Elderly

There are no special dosage recommendations for either elderly patients or children of 12 years and over. The normal adult dose is appropriate unless otherwise recommended by the dentist or the physician.

Children under 12 years of age should not use the product unless recommended by a healthcare professional.


Go to top of the page
4.3 Contraindications

Corsodyl Mouthwash is contra-indicated for patients who have previously shown a hypersensitivity reaction to chlorhexidine. However, such reactions are extremely rare.


Go to top of the page
4.4 Special warnings and precautions for use

For oral (external) use only. Do not swallow.

Keep out of the eyes and ears.

If the mouthwash comes into contact with the eyes, wash out promptly and thoroughly with water.

In case of soreness, swelling or irritation of the mouth, stop using the product and consult a healthcare professional.

A discoloration of the teeth and tongue may occur. The stain is not permanent and can largely be prevented by reducing the consumption of tea, coffee and red wine.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

Chlorhexidine is incompatible with anionic agents.


Go to top of the page
4.6 Pregnancy and lactation

There is no evidence of any adverse events on the foetus arising from the use of Corsodyl Mint Mouthwash during pregnancy or lactation. Therefore, no special precautions are recommended.


Go to top of the page
4.7 Effects on ability to drive and use machines

None have been reported or are known.


Go to top of the page
4.8 Undesirable effects

Discoloration

A superficial discoloration of the dorsum of the tongue may occur. This disappears after treatment is discontinued. Discoloration of the teeth and silicate or composite restorations may also occur. This stain is not permanent and can largely be prevented by brushing with a conventional toothpaste daily before using the mouthwash, or, in the case of dentures, cleaning with a conventional denture cleaner. However, in certain cases a professional prophylaxis (scaling and polishing) may be required to remove the stain completely. Stained anterior tooth-coloured restorations with poor margins or rough surfaces which are not adequately cleaned by professional prophylaxis may require replacement. Similarly where normal tooth brushing is not possible, as for example with intermaxillary fixation, or with extensive orthodontic applicances, scaling and polishing may also be required once the underlying condition has been resolved.

Taste

Transient disturbances of taste sensation and a numbness, tingling or burning sensation of the tongue may occur on initial use of the mouthwash. These effects usually diminish with continued use. If the condition persists, consult a healthcare professional.

Oral desquamation

In cases where oral desquamation occurs, dilution of the mouthwash using 5ml water with 10ml mouthwash, freshly mixed, will often allow continued use of the mouthwash.

Parotid gland swelling

Very occasionally, swelling of the parotid glands during the use of chlorhexidine mouthrinses has been reported. In all cases spontaneous resolution has occurred on discontinuation of treatment.

Irritative skin reactions

Irritative skin reactions to chlorhexidine preparations can occasionally occur.

Generalised reactions

Allergic reactions, hypersensitivity & anaphylaxis to chlorhexidine have also been reported but are extremely rare.


Go to top of the page
4.9 Overdose

This has not been reported.

Accidental Ingestion

Chlorhexidine taken orally is poorly absorbed. Systemic effects are unlikely even if large volumes are ingested. However, gastric lavage may be advisable using milk, raw egg, gelatin or mild soap. Employ supportive measures as appropriate. Due to the alcohol content (7 % v/v), ingestion of large amounts by children requires attention, seek medical advice for appropriate action.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Corsodyl Mouthwash contains 0.2% w/v chlorhexidine gluconate which is an antimicrobial preparation for external use. It is effective against a wide range of gram negative and gram positive vegetative bacteria, yeasts, dermatophyte fungi and lipophilic viruses. It is active against a wide range of important oral pathogens and is therefore effective in the treatment of many common dental conditions.


Go to top of the page
5.2 Pharmacokinetic properties

Because of its cationic nature, chlorhexidine binds strongly to skin, mucosa and tissues and is thus very poorly absorbed. No detectable blood levels have been found following oral use.


Go to top of the page
5.3 Preclinical safety data

Pre-clinical safety studies carried out on chlorhexidine gluconate have not revealed any pertinent findings which are of relevance to the recommended dosage and use of the product and which have not already been mentioned elsewhere in the Summary.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipient(s)

Sorbitol 70% (non-crystallising)

Ethanol (96%)

Macrogolglycerol hydroxystearate

Peppermint oil

Purified water


Go to top of the page
6.2 Incompatibilities

Chlorhexidine is incompatible with anionic agents. Hypochlorite bleaches may cause brown stains to develop in fabrics which have previously been in contact with preparations containing chlorhexidine.


Go to top of the page
6.3 Shelf life

Three years.


Go to top of the page
6.4 Special precautions for storage

Do not store above 25oC. Store in the original container in order to protect from light.


Go to top of the page
6.5 Nature and contents of container

Container

Amber coloured, oriented polyethylene terephthalate (PET) bottles of 300 ml nominal capacity.

Closure

Wadless screw caps made from white, food grade polypropylene.


Go to top of the page
6.6 Special precautions for disposal and other handling

No special requirements.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

GlaxoSmithkline Consumer Healthcare (Ireland) Limited

Stonemasons Way

Rathfarnham

Dublin 16


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PA 678/2/2


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

30 September 1976/10 January 2010


Go to top of the page
10. DATE OF REVISION OF THE TEXT

September 2010



Link to this document from your website:
http://www.medicines.ie/medicine/5829/SPC/Corsodyl+0.2++w+v+Mint+Mouthwash/

Document Links

 
  Link to this page
  View all medicines
from this company
Print this page
View document history
Bookmark and Share

Legal Categories

 
   Product subject to medical
prescription which may not
be renewed (A)
   Product subject to medical
prescription which may
be renewed (B)
   Product subject to
restricted prescription
(C)
   Supply through
general sale
   Supply through
pharmacy only

Active Ingredients

 
   Chlorhexidine digluconate

  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo